What's new

Transfer of marketing authorisation: questions and answers

Transfer of marketing authorisation: questions and answers

Feb 18, 2025 - 15:38
 0
Transfer of marketing authorisation: questions and answers
Transfer of marketing authorisation: questions and answers
Read More

Tags:

Previous Article

Biogen partners with Stoke Therapeutics to sell severe epilepsy drug

Next Article

Changing the labelling and package leaflet (Article 61(3) notifications)

Related Posts

Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine,tenofovir disoproxil, Date of authorisation: 28/04/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0